Clinical study on treatment with Xiaozhi Yanggan tea for mixed hyperlipidemia
10.3969/j.issn.1006-5725.2018.10.038
- VernacularTitle:消脂养肝茶治疗混合型高脂血症患者的疗效
- Author:
Shaoxu CHEN
1
,
2
;
Xiaoyin LIANG
;
Shunhua FAN
;
Yi YANG
Author Information
1. 佛山市中医院三水医院 广东佛山 528100
2. 广州中医药大学 广州 510405
- Keywords:
xiaozhi yanggan tea;
phlegm-damp obstruction;
mixed hyperlipidemia;
clinical study
- From:
The Journal of Practical Medicine
2018;34(10):1730-1733
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of Xiaozhi Yanggan tea on mixed hyperlipidemia with Phlegm-damp obstruction type. Methods According to the inclusion criteria,a total of 80 cases of mixed hy-perlipidemia were randomly divided into treatment group and control group,with 40 cases in each group. All pa-tients were treated with Atorvastatin Calcium capsule and those in the treatment group were additionally treated with Xiaozhi Yanggan tea,for a total of 12 weeks. Two groups of patients were observed for the integral of Tradition-al Chinese Medicine(TCM)syndrome,the change of blood lipids and safety. Results After treatment,the total effective rate for TCM syndrome was 95.00% in treatment group,which was better than 75.00% in control group (P < 0. 05). TC,LDL-C and non-HDL-C levels in the treatment group were lower than those in the control group (P < 0. 05). HDL-C was higher than that in the control group(P < 0.05). TG in the treatment group were lower than that before(P < 0. 05),while it was not obvious in the control group(P > 0.05). No obvious abnormality in hepatorenal function and creatine kinase in the two groups after treatment. Conclusion Xiaozhi Yanggan tea was an effective and safe therapy for mixed hyperlipidemia with Phlegm-damp obstruction type.
